CTRB1 and colorectal carcinoma: Therefore, all MRM results demonstrated that the serum abundance of the six proteins, CELA1, CEL2A, chymopasin, CTRB1, TRY2, and TRY4, reflected tumor development and served as CRC serum biomarkers in this mouse model.